Both genetic2 and pharmacological3,4 experiments in such models have demonstrated that reducing the amount of PrP in the brain is protective against prion disease, inspiring hope that a PrP-lowering therapy could be used to effectively treat, delay, and prevent disease in patients and individuals at risk5. Here, PRNP is linked to prion disease.